Citation
89 FR 6119
Multiple canonical documents share this first-page citation.
- Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization; Guidance for Industry; Correction Wednesday, January 31, 2024 89 FR 6119
- National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Wednesday, January 31, 2024 89 FR 6119
- National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Wednesday, January 31, 2024 89 FR 6119